Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer

Clinical trial NCT00005096 · COMPLETED

Trial details

NCT number: NCT00005096
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 1999-12-01
Primary completion: 2002-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.